Trial AbbVie M12-914 (brocade-3)

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial

Trial acronym

AbbVie M12-914 (brocade-3)

Full title

A Phase III Randomized, Placebo-Controlled Trial of Carboplatin and Paclitaxel with or without the PARP Inhibitor Veliparib (ABT-888) in Metastatic or Locally Advanced Unresectable BRCA-Associated Breast Cancer

Responsible organization

Frauenklinik Frauenklinik Ismaninger Str. 22 81675 München Germany

Indications

Classification	Code	Description
-		Breastcancer

Trial design

Phase

III

Status

Recruitment finished

Votes

Initiiation & lock

Date of lock (planned / actual)

Unknown / Unknown

Therapy

Zielgerichtet - Therapieart: palliativ

Participants

	Function	Prename	Surname	Organization
	Responsible contact	Johannes	Ettl	Frauenklinik Frauenklinik Ismaninger Str. 22 81675 München Germany